Published in Obesity and Diabetes Week, December 12th, 2005
According to recent research from Japan, "Peroxidized phospholipid-mediated cytotoxicity is involved in the pathophysiology of diseases [i.e. an abnormal increase of phosphatidylcholine hydroperoxide (PCOOH) in plasma of type 2 diabetic patients]. The PCOOH accumulation may relate to Amadori-glycated phosphatidylethanolamine (Amadori-PE; deoxy-d-fructosyl phosphatidylethanolamine), because Amadori-PE causes oxidative stress."
"However," remarked K. Nakagawa and colleagues at Tohoku...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.